location	cause	percent	year	text
Global	Gout	0.704872755871372	1990	70.5%
Global	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.295127244128628	1990	29.5%
Taiwan (Province of China)	Gout	0.89580092893366	1990	89.6%
Taiwan (Province of China)	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.10419907106634	1990	10.4%
Democratic Korea	Gout	0.718233890636484	1990	71.8%
Democratic Korea	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.281766109363516	1990	28.2%
China	Gout	0.605419584563517	1990	60.5%
China	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.394580415436483	1990	39.5%
East Asia	Gout	0.613358405461351	1990	61.3%
East Asia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.386641594538649	1990	38.7%
Lao People's Democratic Republic	Gout	0.687639076836209	1990	68.8%
Lao People's Democratic Republic	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.312360923163791	1990	31.2%
Cambodia	Gout	0.67466088853624	1990	67.5%
Cambodia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.32533911146376	1990	32.5%
Indonesia	Gout	0.669204161885509	1990	66.9%
Indonesia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.330795838114491	1990	33.1%
Malaysia	Gout	0.522545815360946	1990	52.3%
Malaysia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.477454184639054	1990	47.7%
Southeast Asia	Gout	0.591965973953842	1990	59.2%
Southeast Asia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.408034026046158	1990	40.8%
Sri Lanka	Gout	0.833356744067294	1990	83.3%
Sri Lanka	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.166643255932706	1990	16.7%
Myanmar	Gout	0.684725674925759	1990	68.5%
Myanmar	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.315274325074241	1990	31.5%
Thailand	Gout	0.503856572119179	1990	50.4%
Thailand	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.496143427880821	1990	49.6%
Philippines	Gout	0.613491348303752	1990	61.3%
Philippines	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.386508651696248	1990	38.7%
Maldives	Gout	0.692175117154123	1990	69.2%
Maldives	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.307824882845877	1990	30.8%
Viet Nam	Gout	0.418972660874696	1990	41.9%
Viet Nam	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.581027339125304	1990	58.1%
Timor-Leste	Gout	0.754934103513428	1990	75.5%
Timor-Leste	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.245065896486571	1990	24.5%
Fiji	Gout	0.717329126009514	1990	71.7%
Fiji	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.282670873990486	1990	28.3%
Oceania	Gout	0.61597679224822	1990	61.6%
Oceania	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.38402320775178	1990	38.4%
Micronesia (Federated States of)	Gout	0.718455689010722	1990	71.8%
Micronesia (Federated States of)	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.281544310989278	1990	28.2%
Kiribati	Gout	0.700670544076475	1990	70.1%
Kiribati	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.299329455923525	1990	29.9%
Marshall Islands	Gout	0.404010163474572	1990	40.4%
Marshall Islands	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.595989836525427	1990	59.6%
Papua New Guinea	Gout	0.590009266617378	1990	59%
Papua New Guinea	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.409990733382622	1990	41%
Solomon Islands	Gout	0.609400582393288	1990	60.9%
Solomon Islands	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.390599417606712	1990	39.1%
Vanuatu	Gout	0.70979463316949	1990	71%
Vanuatu	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.290205366830511	1990	29%
Tonga	Gout	0.306909382416321	1990	30.7%
Tonga	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.693090617583679	1990	69.3%
Samoa	Gout	0.801573681133468	1990	80.2%
Samoa	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.198426318866532	1990	19.8%
Georgia	Gout	0.671774752614703	1990	67.2%
Georgia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.328225247385297	1990	32.8%
Armenia	Gout	0.526308205916375	1990	52.6%
Armenia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.473691794083625	1990	47.4%
Central Asia	Gout	0.582041025690722	1990	58.2%
Central Asia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.417958974309278	1990	41.8%
Azerbaijan	Gout	0.601602187390403	1990	60.2%
Azerbaijan	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.398397812609597	1990	39.8%
Kazakhstan	Gout	0.498892659177479	1990	49.9%
Kazakhstan	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.501107340822521	1990	50.1%
Mongolia	Gout	0.213909735257046	1990	21.4%
Mongolia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.786090264742954	1990	78.6%
Turkmenistan	Gout	0.684055455321591	1990	68.4%
Turkmenistan	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.315944544678409	1990	31.6%
Kyrgyzstan	Gout	0.811369490139751	1990	81.1%
Kyrgyzstan	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.188630509860249	1990	18.9%
Uzbekistan	Gout	0.692536548851104	1990	69.3%
Uzbekistan	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.307463451148896	1990	30.7%
Tajikistan	Gout	0.674951222699634	1990	67.5%
Tajikistan	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.325048777300366	1990	32.5%
Albania	Gout	0.393069292762877	1990	39.3%
Albania	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.606930707237123	1990	60.7%
Bulgaria	Gout	0.489937543205846	1990	49%
Bulgaria	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.510062456794154	1990	51%
Central Europe	Gout	0.698548442874195	1990	69.9%
Central Europe	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.301451557125805	1990	30.1%
Bosnia and Herzegovina	Gout	0.460344215779483	1990	46%
Bosnia and Herzegovina	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.539655784220517	1990	54%
Hungary	Gout	0.69961355272824	1990	70%
Hungary	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.30038644727176	1990	30%
Croatia	Gout	0.735262268393091	1990	73.5%
Croatia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.264737731606909	1990	26.5%
North Macedonia	Gout	0.484781809853096	1990	48.5%
North Macedonia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.515218190146904	1990	51.5%
Czechia	Gout	0.619727010961638	1990	62%
Czechia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.380272989038362	1990	38%
Poland	Gout	0.922520266012606	1990	92.3%
Poland	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.0774797339873943	1990	7.7%
Serbia	Gout	0.58196611747924	1990	58.2%
Serbia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.41803388252076	1990	41.8%
Romania	Gout	0.857533924644346	1990	85.8%
Romania	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.142466075355654	1990	14.2%
Montenegro	Gout	0.577603983663243	1990	57.8%
Montenegro	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.422396016336758	1990	42.2%
Slovakia	Gout	0.535486111839518	1990	53.5%
Slovakia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.464513888160482	1990	46.5%
Eastern Europe	Gout	0.851744734729086	1990	85.2%
Eastern Europe	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.148255265270914	1990	14.8%
Estonia	Gout	0.758811733025142	1990	75.9%
Estonia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.241188266974858	1990	24.1%
Slovenia	Gout	0.536533146051934	1990	53.7%
Slovenia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.463466853948066	1990	46.3%
Belarus	Gout	0.816898060283931	1990	81.7%
Belarus	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.183101939716069	1990	18.3%
Latvia	Gout	0.806151215611364	1990	80.6%
Latvia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.193848784388636	1990	19.4%
Moldova	Gout	0.790261047480596	1990	79%
Moldova	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.209738952519404	1990	21%
Ukraine	Gout	0.861403345489579	1990	86.1%
Ukraine	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.138596654510421	1990	13.9%
Lithuania	Gout	0.873049863589542	1990	87.3%
Lithuania	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.126950136410458	1990	12.7%
Brunei Darussalam	Gout	0.659675829510232	1990	66%
Brunei Darussalam	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.340324170489768	1990	34%
Russian Federation	Gout	0.853604650969301	1990	85.4%
Russian Federation	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.146395349030699	1990	14.6%
High-income Asia Pacific	Gout	0.612649383047173	1990	61.3%
High-income Asia Pacific	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.387350616952827	1990	38.7%
Japan	Gout	0.664368272723674	1990	66.4%
Japan	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.335631727276326	1990	33.6%
Singapore	Gout	0.787092127582824	1990	78.7%
Singapore	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.212907872417176	1990	21.3%
Australia	Gout	0.929181187975256	1990	92.9%
Australia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.070818812024744	1990	7.1%
Korea	Gout	0.400352655283012	1990	40%
Korea	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.599647344716988	1990	60%
Australasia	Gout	0.929787005259199	1990	93%
Australasia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.0702129947408013	1990	7%
New Zealand	Gout	0.931937817743093	1990	93.2%
New Zealand	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.0680621822569068	1990	6.8%
Andorra	Gout	0.783203789748059	1990	78.3%
Andorra	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.216796210251941	1990	21.7%
Belgium	Gout	0.905787308231922	1990	90.6%
Belgium	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.0942126917680776	1990	9.4%
Western Europe	Gout	0.847144231291845	1990	84.7%
Western Europe	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.152855768708155	1990	15.3%
Austria	Gout	0.8785341848951	1990	87.9%
Austria	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.1214658151049	1990	12.1%
Cyprus	Gout	0.87222348648753	1990	87.2%
Cyprus	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.12777651351247	1990	12.8%
Finland	Gout	0.815113895393435	1990	81.5%
Finland	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.184886104606565	1990	18.5%
Germany	Gout	0.847236269172915	1990	84.7%
Germany	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.152763730827085	1990	15.3%
Denmark	Gout	0.958396579183458	1990	95.8%
Denmark	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.0416034208165418	1990	
France	Gout	0.822681320398328	1990	82.3%
France	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.177318679601672	1990	17.7%
Greece	Gout	0.904356005325062	1990	90.4%
Greece	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.0956439946749381	1990	9.6%
Ireland	Gout	0.902119255780132	1990	90.2%
Ireland	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.0978807442198684	1990	9.8%
Italy	Gout	0.769039025352381	1990	76.9%
Italy	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.230960974647619	1990	23.1%
Iceland	Gout	0.888349594170667	1990	88.8%
Iceland	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.111650405829333	1990	11.2%
Israel	Gout	0.881532545190572	1990	88.2%
Israel	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.118467454809428	1990	11.8%
Luxembourg	Gout	0.848156032364512	1990	84.8%
Luxembourg	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.151843967635488	1990	15.2%
Netherlands	Gout	0.915127057359787	1990	91.5%
Netherlands	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.0848729426402129	1990	8.5%
Malta	Gout	0.899341561584823	1990	89.9%
Malta	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.100658438415177	1990	10.1%
Norway	Gout	0.914858892066703	1990	91.5%
Norway	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.0851411079332966	1990	8.5%
Spain	Gout	0.824245557996045	1990	82.4%
Spain	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.175754442003955	1990	17.6%
Switzerland	Gout	0.847882597610229	1990	84.8%
Switzerland	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.152117402389771	1990	15.2%
Portugal	Gout	0.878864699689242	1990	87.9%
Portugal	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.121135300310758	1990	12.1%
Sweden	Gout	0.894429256682992	1990	89.4%
Sweden	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.105570743317008	1990	10.6%
United Kingdom	Gout	0.888730490464586	1990	88.9%
United Kingdom	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.111269509535414	1990	11.1%
Argentina	Gout	0.964828544649427	1990	96.5%
Argentina	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.0351714553505729	1990	
Uruguay	Gout	0.934927633576249	1990	93.5%
Uruguay	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.0650723664237511	1990	6.5%
Southern Latin America	Gout	0.950660418581475	1990	95.1%
Southern Latin America	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.0493395814185247	1990	
Chile	Gout	0.917929987168661	1990	91.8%
Chile	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.0820700128313393	1990	8.2%
High-income North America	Gout	0.895026423368012	1990	89.5%
High-income North America	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.104973576631988	1990	10.5%
Caribbean	Gout	0.722111515692413	1990	72.2%
Caribbean	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.277888484307587	1990	27.8%
United States of America	Gout	0.893267425996578	1990	89.3%
United States of America	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.106732574003422	1990	10.7%
Canada	Gout	0.909660358700852	1990	91%
Canada	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.0903396412991477	1990	9%
Antigua and Barbuda	Gout	0.641440683409268	1990	64.1%
Antigua and Barbuda	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.358559316590732	1990	35.9%
Cuba	Gout	0.745549141318447	1990	74.6%
Cuba	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.254450858681553	1990	25.4%
Barbados	Gout	0.670354038098559	1990	67%
Barbados	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.329645961901441	1990	33%
Belize	Gout	0.65694413576601	1990	65.7%
Belize	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.34305586423399	1990	34.3%
Bahamas	Gout	0.652083834882971	1990	65.2%
Bahamas	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.347916165117029	1990	34.8%
Dominica	Gout	0.693132391670855	1990	69.3%
Dominica	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.306867608329145	1990	30.7%
Grenada	Gout	0.763199474862938	1990	76.3%
Grenada	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.236800525137062	1990	23.7%
Dominican Republic	Gout	0.75401010510882	1990	75.4%
Dominican Republic	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.24598989489118	1990	24.6%
Guyana	Gout	0.654814436259971	1990	65.5%
Guyana	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.345185563740029	1990	34.5%
Jamaica	Gout	0.728290849636194	1990	72.8%
Jamaica	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.271709150363807	1990	27.2%
Saint Vincent and the Grenadines	Gout	0.723289370660225	1990	72.3%
Saint Vincent and the Grenadines	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.276710629339775	1990	27.7%
Haiti	Gout	0.793612394136854	1990	79.4%
Haiti	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.206387605863146	1990	20.6%
Saint Lucia	Gout	0.741500487074803	1990	74.2%
Saint Lucia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.258499512925197	1990	25.8%
Suriname	Gout	0.637822463942444	1990	63.8%
Suriname	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.362177536057556	1990	36.2%
Andean Latin America	Gout	0.776351240564876	1990	77.6%
Andean Latin America	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.223648759435124	1990	22.4%
Ecuador	Gout	0.696845183651717	1990	69.7%
Ecuador	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.303154816348283	1990	30.3%
Trinidad and Tobago	Gout	0.684346927772406	1990	68.4%
Trinidad and Tobago	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.315653072227594	1990	31.6%
Bolivia (Plurinational State of)	Gout	0.771641925290881	1990	77.2%
Bolivia (Plurinational State of)	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.228358074709119	1990	22.8%
Peru	Gout	0.831148984385091	1990	83.1%
Peru	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.168851015614909	1990	16.9%
Colombia	Gout	0.661037972660641	1990	66.1%
Colombia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.338962027339359	1990	33.9%
El Salvador	Gout	0.777943734671861	1990	77.8%
El Salvador	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.222056265328139	1990	22.2%
Central Latin America	Gout	0.666417509215396	1990	66.6%
Central Latin America	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.333582490784604	1990	33.4%
Costa Rica	Gout	0.602755937326937	1990	60.3%
Costa Rica	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.397244062673063	1990	39.7%
Guatemala	Gout	0.527529161015516	1990	52.8%
Guatemala	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.472470838984484	1990	47.2%
Mexico	Gout	0.666988809998333	1990	66.7%
Mexico	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.333011190001667	1990	33.3%
Honduras	Gout	0.702490345419604	1990	70.2%
Honduras	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.297509654580396	1990	29.8%
Nicaragua	Gout	0.663483765178478	1990	66.3%
Nicaragua	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.336516234821522	1990	33.7%
Venezuela (Bolivarian Republic of)	Gout	0.703849172177394	1990	70.4%
Venezuela (Bolivarian Republic of)	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.296150827822606	1990	29.6%
Brazil	Gout	0.730659630482178	1990	73.1%
Brazil	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.269340369517822	1990	26.9%
Panama	Gout	0.705700625714117	1990	70.6%
Panama	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.294299374285883	1990	29.4%
Tropical Latin America	Gout	0.732490523974013	1990	73.2%
Tropical Latin America	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.267509476025987	1990	26.8%
Paraguay	Gout	0.814360313743109	1990	81.4%
Paraguay	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.185639686256891	1990	18.6%
North Africa and Middle East	Gout	0.528580497362831	1990	52.9%
North Africa and Middle East	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.471419502637169	1990	47.1%
Bahrain	Gout	0.654411265170122	1990	65.4%
Bahrain	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.345588734829878	1990	34.6%
Algeria	Gout	0.859061807925688	1990	85.9%
Algeria	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.140938192074312	1990	14.1%
Egypt	Gout	0.273873186724678	1990	27.4%
Egypt	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.726126813275322	1990	72.6%
Iraq	Gout	0.578656089828672	1990	57.9%
Iraq	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.421343910171328	1990	42.1%
Iran (Islamic Republic of)	Gout	0.651202798408584	1990	65.1%
Iran (Islamic Republic of)	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.348797201591417	1990	34.9%
Kuwait	Gout	0.831557534998898	1990	83.2%
Kuwait	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.168442465001102	1990	16.8%
Jordan	Gout	0.808523440155643	1990	80.9%
Jordan	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.191476559844357	1990	19.1%
Lebanon	Gout	0.79598684535983	1990	79.6%
Lebanon	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.20401315464017	1990	20.4%
Libya	Gout	0.622888261674206	1990	62.3%
Libya	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.377111738325794	1990	37.7%
Morocco	Gout	0.61425148320635	1990	61.4%
Morocco	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.38574851679365	1990	38.6%
Palestine	Gout	0.57127952949452	1990	57.1%
Palestine	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.42872047050548	1990	42.9%
Oman	Gout	0.569990415049387	1990	57%
Oman	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.430009584950613	1990	43%
Qatar	Gout	0.685273737516196	1990	68.5%
Qatar	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.314726262483804	1990	31.5%
Saudi Arabia	Gout	0.485344195267833	1990	48.5%
Saudi Arabia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.514655804732167	1990	51.5%
Syrian Arab Republic	Gout	0.624501031216606	1990	62.5%
Syrian Arab Republic	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.375498968783395	1990	37.5%
Tunisia	Gout	0.859907362512671	1990	86%
Tunisia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.140092637487329	1990	14%
Turkey	Gout	0.797053553781604	1990	79.7%
Turkey	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.202946446218396	1990	20.3%
United Arab Emirates	Gout	0.770835411488299	1990	77.1%
United Arab Emirates	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.229164588511701	1990	22.9%
Yemen	Gout	0.636954653569647	1990	63.7%
Yemen	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.363045346430353	1990	36.3%
South Asia	Gout	0.722013392827681	1990	72.2%
South Asia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.277986607172319	1990	27.8%
Afghanistan	Gout	0.66455149738022	1990	66.5%
Afghanistan	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.33544850261978	1990	33.5%
Bangladesh	Gout	0.749642437826096	1990	75%
Bangladesh	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.250357562173904	1990	25%
Bhutan	Gout	0.766965334523606	1990	76.7%
Bhutan	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.233034665476394	1990	23.3%
India	Gout	0.715711578459483	1990	71.6%
India	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.284288421540517	1990	28.4%
Nepal	Gout	0.810042449700506	1990	81%
Nepal	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.189957550299494	1990	19%
Pakistan	Gout	0.731907031924215	1990	73.2%
Pakistan	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.268092968075785	1990	26.8%
Central Sub-Saharan Africa	Gout	0.313689536301186	1990	31.4%
Central Sub-Saharan Africa	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.686310463698814	1990	68.6%
Angola	Gout	0.348143775957629	1990	34.8%
Angola	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.651856224042371	1990	65.2%
Central African Republic	Gout	0.45091374144201	1990	45.1%
Central African Republic	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.54908625855799	1990	54.9%
Congo	Gout	0.541306010685805	1990	54.1%
Congo	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.458693989314195	1990	45.9%
Democratic the Congo	Gout	0.288474234678057	1990	28.8%
Democratic the Congo	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.711525765321943	1990	71.2%
Equatorial Guinea	Gout	0.547678091556292	1990	54.8%
Equatorial Guinea	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.452321908443708	1990	45.2%
Gabon	Gout	0.436304409946217	1990	43.6%
Gabon	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.563695590053783	1990	56.4%
Eastern Sub-Saharan Africa	Gout	0.588794558526024	1990	58.9%
Eastern Sub-Saharan Africa	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.411205441473976	1990	41.1%
Burundi	Gout	0.695828281436101	1990	69.6%
Burundi	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.304171718563899	1990	30.4%
Comoros	Gout	0.720420620110981	1990	72%
Comoros	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.27957937988902	1990	28%
Djibouti	Gout	0.485324953558738	1990	48.5%
Djibouti	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.514675046441262	1990	51.5%
Eritrea	Gout	0.599064944431728	1990	59.9%
Eritrea	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.400935055568272	1990	40.1%
Ethiopia	Gout	0.747786750933479	1990	74.8%
Ethiopia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.252213249066521	1990	25.2%
Kenya	Gout	0.549616114096761	1990	55%
Kenya	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.450383885903239	1990	45%
Madagascar	Gout	0.420686015404928	1990	42.1%
Madagascar	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.579313984595072	1990	57.9%
Malawi	Gout	0.635755902052434	1990	63.6%
Malawi	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.364244097947566	1990	36.4%
Mozambique	Gout	0.491251934332567	1990	49.1%
Mozambique	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.508748065667433	1990	50.9%
Mauritius	Gout	0.726621832028033	1990	72.7%
Mauritius	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.273378167971967	1990	27.3%
Seychelles	Gout	0.576668589881246	1990	57.7%
Seychelles	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.423331410118754	1990	42.3%
Rwanda	Gout	0.509664611537869	1990	51%
Rwanda	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.49033538846213	1990	49%
Somalia	Gout	0.513345866273794	1990	51.3%
Somalia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.486654133726206	1990	48.7%
Uganda	Gout	0.52000271934765	1990	52%
Uganda	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.47999728065235	1990	48%
United Tanzania	Gout	0.656594166281584	1990	65.7%
United Tanzania	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.343405833718416	1990	34.3%
Southern Sub-Saharan Africa	Gout	0.605830395356361	1990	60.6%
Southern Sub-Saharan Africa	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.394169604643638	1990	39.4%
Zambia	Gout	0.627717909127079	1990	62.8%
Zambia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.372282090872921	1990	37.2%
Botswana	Gout	0.748167521036548	1990	74.8%
Botswana	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.251832478963452	1990	25.2%
Lesotho	Gout	0.502513813468899	1990	50.3%
Lesotho	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.497486186531101	1990	49.7%
Namibia	Gout	0.765191664819921	1990	76.5%
Namibia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.234808335180079	1990	23.5%
South Africa	Gout	0.613555823050933	1990	61.4%
South Africa	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.386444176949067	1990	38.6%
Eswatini	Gout	0.49515830158711	1990	49.5%
Eswatini	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.50484169841289	1990	50.5%
Zimbabwe	Gout	0.561541874140766	1990	56.2%
Zimbabwe	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.438458125859234	1990	43.8%
Benin	Gout	0.710293197601279	1990	71%
Benin	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.289706802398721	1990	29%
Western Sub-Saharan Africa	Gout	0.40471160848245	1990	40.5%
Western Sub-Saharan Africa	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.59528839151755	1990	59.5%
Burkina Faso	Gout	0.486607321262855	1990	48.7%
Burkina Faso	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.513392678737145	1990	51.3%
Cameroon	Gout	0.285451375282122	1990	28.5%
Cameroon	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.714548624717878	1990	71.5%
Cabo Verde	Gout	0.404276741844908	1990	40.4%
Cabo Verde	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.595723258155092	1990	59.6%
Chad	Gout	0.227993455606457	1990	22.8%
Chad	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.772006544393543	1990	77.2%
Cote d'Ivoire	Gout	0.569863516047406	1990	57%
Cote d'Ivoire	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.430136483952594	1990	43%
Gambia	Gout	0.342493220844978	1990	34.2%
Gambia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.657506779155022	1990	65.8%
Ghana	Gout	0.310009989406274	1990	31%
Ghana	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.689990010593726	1990	69%
Guinea	Gout	0.330382609989164	1990	33%
Guinea	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.669617390010836	1990	67%
Guinea-Bissau	Gout	0.452114535515548	1990	45.2%
Guinea-Bissau	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.547885464484452	1990	54.8%
Liberia	Gout	0.257594692051041	1990	25.8%
Liberia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.742405307948959	1990	74.2%
Mali	Gout	0.281740157641755	1990	28.2%
Mali	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.718259842358245	1990	71.8%
Mauritania	Gout	0.214681332173398	1990	21.5%
Mauritania	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.785318667826602	1990	78.5%
Niger	Gout	0.58201264949834	1990	58.2%
Niger	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.41798735050166	1990	41.8%
Sao Tome and Principe	Gout	0.447739316532191	1990	44.8%
Sao Tome and Principe	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.552260683467809	1990	55.2%
Nigeria	Gout	0.46834393301082	1990	46.8%
Nigeria	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.53165606698918	1990	53.2%
Senegal	Gout	0.38604621223821	1990	38.6%
Senegal	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.61395378776179	1990	61.4%
Sierra Leone	Gout	0.31948181121055	1990	31.9%
Sierra Leone	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.68051818878945	1990	68.1%
Togo	Gout	0.403601907349979	1990	40.4%
Togo	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.596398092650021	1990	59.6%
Bermuda	Gout	0.770794515993531	1990	77.1%
Bermuda	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.229205484006469	1990	22.9%
American Samoa	Gout	0.674817593171523	1990	67.5%
American Samoa	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.325182406828477	1990	32.5%
Cook Islands	Gout	0.485049754715662	1990	48.5%
Cook Islands	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.514950245284339	1990	51.5%
Guam	Gout	0.904374033760201	1990	90.4%
Guam	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.0956259662397987	1990	9.6%
Greenland	Gout	0.810721994433038	1990	81.1%
Greenland	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.189278005566962	1990	18.9%
Monaco	Gout	0.804986910172728	1990	80.5%
Monaco	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.195013089827271	1990	19.5%
Niue	Gout	0.648526710536434	1990	64.9%
Niue	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.351473289463566	1990	35.1%
Nauru	Gout	0.398546364864418	1990	39.9%
Nauru	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.601453635135582	1990	60.1%
Northern Mariana Islands	Gout	0.734219831524496	1990	73.4%
Northern Mariana Islands	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.265780168475504	1990	26.6%
Puerto Rico	Gout	0.647001751196955	1990	64.7%
Puerto Rico	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.352998248803045	1990	35.3%
San Marino	Gout	0.901043099988877	1990	90.1%
San Marino	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.0989569000111233	1990	9.9%
Saint Kitts and Nevis	Gout	0.625123988014822	1990	62.5%
Saint Kitts and Nevis	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.374876011985178	1990	37.5%
Palau	Gout	0.653665106561862	1990	65.4%
Palau	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.346334893438138	1990	34.6%
Tokelau	Gout	0.655367874556326	1990	65.5%
Tokelau	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.344632125443674	1990	34.5%
United States Virgin Islands	Gout	0.705056888782344	1990	70.5%
United States Virgin Islands	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.294943111217656	1990	29.5%
South Sudan	Gout	0.560430882557038	1990	56%
South Sudan	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.439569117442962	1990	44%
Sudan	Gout	0.525813700057917	1990	52.6%
Sudan	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.474186299942083	1990	47.4%
Tuvalu	Gout	0.571460878078226	1990	57.1%
Tuvalu	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.428539121921774	1990	42.9%
Low-middle SDI	Gout	0.670570304447904	1990	67.1%
Low-middle SDI	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.329429695552096	1990	32.9%
High-middle SDI	Gout	0.596518401249128	1990	59.7%
High-middle SDI	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.403481598750872	1990	40.3%
Low SDI	Gout	0.541517501912594	1990	54.2%
Low SDI	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.458482498087406	1990	45.8%
Middle SDI	Gout	0.532329711071655	1990	53.2%
Middle SDI	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.467670288928345	1990	46.8%
Global	Gout	0.692069348866727	2023	69.2%
Global	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.307930651133273	2023	30.8%
Taiwan (Province of China)	Gout	0.708454994677653	2023	70.8%
Taiwan (Province of China)	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.291545005322347	2023	29.2%
Democratic Korea	Gout	0.722265272690986	2023	72.2%
Democratic Korea	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.277734727309014	2023	27.8%
China	Gout	0.725978694762619	2023	72.6%
China	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.274021305237381	2023	27.4%
East Asia	Gout	0.725382967387039	2023	72.5%
East Asia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.274617032612961	2023	27.5%
Lao People's Democratic Republic	Gout	0.670366142898276	2023	67%
Lao People's Democratic Republic	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.329633857101724	2023	33%
Cambodia	Gout	0.780781816188942	2023	78.1%
Cambodia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.219218183811058	2023	21.9%
Indonesia	Gout	0.646957539962498	2023	64.7%
Indonesia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.353042460037502	2023	35.3%
Malaysia	Gout	0.500408337220226	2023	50%
Malaysia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.499591662779774	2023	50%
Southeast Asia	Gout	0.62686658826835	2023	62.7%
Southeast Asia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.37313341173165	2023	37.3%
Sri Lanka	Gout	0.772365164495092	2023	77.2%
Sri Lanka	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.227634835504908	2023	22.8%
Myanmar	Gout	0.684162419659442	2023	68.4%
Myanmar	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.315837580340558	2023	31.6%
Thailand	Gout	0.561804294721804	2023	56.2%
Thailand	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.438195705278196	2023	43.8%
Philippines	Gout	0.689210244312709	2023	68.9%
Philippines	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.310789755687291	2023	31.1%
Maldives	Gout	0.741849494545125	2023	74.2%
Maldives	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.258150505454875	2023	25.8%
Viet Nam	Gout	0.607599433992853	2023	60.8%
Viet Nam	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.392400566007147	2023	39.2%
Timor-Leste	Gout	0.804372700242994	2023	80.4%
Timor-Leste	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.195627299757006	2023	19.6%
Fiji	Gout	0.550426181728633	2023	55%
Fiji	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.449573818271366	2023	45%
Oceania	Gout	0.578799428832468	2023	57.9%
Oceania	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.421200571167532	2023	42.1%
Micronesia (Federated States of)	Gout	0.692591408078113	2023	69.3%
Micronesia (Federated States of)	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.307408591921887	2023	30.7%
Kiribati	Gout	0.596443418610844	2023	59.6%
Kiribati	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.403556581389156	2023	40.4%
Marshall Islands	Gout	0.273293335513621	2023	27.3%
Marshall Islands	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.726706664486379	2023	72.7%
Papua New Guinea	Gout	0.61119790916853	2023	61.1%
Papua New Guinea	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.38880209083147	2023	38.9%
Solomon Islands	Gout	0.551651950602831	2023	55.2%
Solomon Islands	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.448348049397169	2023	44.8%
Vanuatu	Gout	0.636981395269491	2023	63.7%
Vanuatu	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.363018604730509	2023	36.3%
Tonga	Gout	0.225199942587174	2023	22.5%
Tonga	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.774800057412826	2023	77.5%
Samoa	Gout	0.666475387078999	2023	66.6%
Samoa	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.333524612921001	2023	33.4%
Georgia	Gout	0.687067264420608	2023	68.7%
Georgia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.312932735579393	2023	31.3%
Armenia	Gout	0.693541964411337	2023	69.4%
Armenia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.306458035588663	2023	30.6%
Central Asia	Gout	0.613800288978578	2023	61.4%
Central Asia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.386199711021422	2023	38.6%
Azerbaijan	Gout	0.58716813258543	2023	58.7%
Azerbaijan	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.41283186741457	2023	41.3%
Kazakhstan	Gout	0.746323581654584	2023	74.6%
Kazakhstan	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.253676418345416	2023	25.4%
Mongolia	Gout	0.144241923293868	2023	14.4%
Mongolia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.855758076706132	2023	85.6%
Turkmenistan	Gout	0.669901948366959	2023	67%
Turkmenistan	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.330098051633041	2023	33%
Kyrgyzstan	Gout	0.751620834847498	2023	75.2%
Kyrgyzstan	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.248379165152502	2023	24.8%
Uzbekistan	Gout	0.670623243763134	2023	67.1%
Uzbekistan	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.329376756236865	2023	32.9%
Tajikistan	Gout	0.605387125590657	2023	60.5%
Tajikistan	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.394612874409343	2023	39.5%
Albania	Gout	0.476445830912968	2023	47.6%
Albania	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.523554169087032	2023	52.4%
Bulgaria	Gout	0.708156698039416	2023	70.8%
Bulgaria	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.291843301960584	2023	29.2%
Central Europe	Gout	0.694420484247417	2023	69.4%
Central Europe	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.305579515752583	2023	30.6%
Bosnia and Herzegovina	Gout	0.467598909621011	2023	46.8%
Bosnia and Herzegovina	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.532401090378989	2023	53.2%
Hungary	Gout	0.764429866745386	2023	76.4%
Hungary	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.235570133254614	2023	23.6%
Croatia	Gout	0.634886581864748	2023	63.5%
Croatia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.365113418135252	2023	36.5%
North Macedonia	Gout	0.494798866163966	2023	49.5%
North Macedonia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.505201133836034	2023	50.5%
Czechia	Gout	0.733624520416428	2023	73.4%
Czechia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.266375479583572	2023	26.6%
Poland	Gout	0.795128023548489	2023	79.5%
Poland	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.204871976451511	2023	20.5%
Serbia	Gout	0.560373308815238	2023	56%
Serbia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.439626691184762	2023	44%
Romania	Gout	0.697406886833443	2023	69.7%
Romania	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.302593113166557	2023	30.3%
Montenegro	Gout	0.477632835769289	2023	47.8%
Montenegro	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.522367164230711	2023	52.2%
Slovakia	Gout	0.657009310347051	2023	65.7%
Slovakia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.342990689652949	2023	34.3%
Eastern Europe	Gout	0.780110888106989	2023	78%
Eastern Europe	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.219889111893011	2023	22%
Estonia	Gout	0.708051351764393	2023	70.8%
Estonia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.291948648235607	2023	29.2%
Slovenia	Gout	0.543215519017242	2023	54.3%
Slovenia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.456784480982758	2023	45.7%
Belarus	Gout	0.741649398090734	2023	74.2%
Belarus	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.258350601909266	2023	25.8%
Latvia	Gout	0.742305140681357	2023	74.2%
Latvia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.257694859318643	2023	25.8%
Moldova	Gout	0.754889943235707	2023	75.5%
Moldova	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.245110056764293	2023	24.5%
Ukraine	Gout	0.856051280059198	2023	85.6%
Ukraine	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.143948719940802	2023	14.4%
Lithuania	Gout	0.73354084696736	2023	73.4%
Lithuania	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.26645915303264	2023	26.6%
Brunei Darussalam	Gout	0.694395109709124	2023	69.4%
Brunei Darussalam	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.305604890290876	2023	30.6%
Russian Federation	Gout	0.765916984524185	2023	76.6%
Russian Federation	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.234083015475815	2023	23.4%
High-income Asia Pacific	Gout	0.751087674577069	2023	75.1%
High-income Asia Pacific	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.248912325422931	2023	24.9%
Japan	Gout	0.815934257235346	2023	81.6%
Japan	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.184065742764654	2023	18.4%
Singapore	Gout	0.860324249087094	2023	86%
Singapore	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.139675750912906	2023	14%
Australia	Gout	0.812434989229025	2023	81.2%
Australia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.187565010770975	2023	18.8%
Korea	Gout	0.581141413000782	2023	58.1%
Korea	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.418858586999217	2023	41.9%
Australasia	Gout	0.819963261411405	2023	82%
Australasia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.180036738588595	2023	18%
New Zealand	Gout	0.856995591539558	2023	85.7%
New Zealand	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.143004408460442	2023	14.3%
Andorra	Gout	0.740905815223122	2023	74.1%
Andorra	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.259094184776878	2023	25.9%
Belgium	Gout	0.832364994007168	2023	83.2%
Belgium	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.167635005992832	2023	16.8%
Western Europe	Gout	0.77597667956684	2023	77.6%
Western Europe	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.22402332043316	2023	22.4%
Austria	Gout	0.803508334115131	2023	80.4%
Austria	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.196491665884869	2023	19.6%
Cyprus	Gout	0.831074444827364	2023	83.1%
Cyprus	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.168925555172636	2023	16.9%
Finland	Gout	0.739709777963826	2023	74%
Finland	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.260290222036174	2023	26%
Germany	Gout	0.765407997289965	2023	76.5%
Germany	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.234592002710035	2023	23.5%
Denmark	Gout	0.854462742908394	2023	85.4%
Denmark	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.145537257091606	2023	14.6%
France	Gout	0.7575188254231	2023	75.8%
France	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.2424811745769	2023	24.2%
Greece	Gout	0.804046562988413	2023	80.4%
Greece	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.195953437011587	2023	19.6%
Ireland	Gout	0.80900027210333	2023	80.9%
Ireland	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.19099972789667	2023	19.1%
Italy	Gout	0.844283192404926	2023	84.4%
Italy	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.155716807595073	2023	15.6%
Iceland	Gout	0.817430718525011	2023	81.7%
Iceland	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.182569281474989	2023	18.3%
Israel	Gout	0.878242603678303	2023	87.8%
Israel	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.121757396321697	2023	12.2%
Luxembourg	Gout	0.79301503094627	2023	79.3%
Luxembourg	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.20698496905373	2023	20.7%
Netherlands	Gout	0.814919980734876	2023	81.5%
Netherlands	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.185080019265124	2023	18.5%
Malta	Gout	0.873400166696349	2023	87.3%
Malta	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.126599833303651	2023	12.7%
Norway	Gout	0.825153462104592	2023	82.5%
Norway	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.174846537895408	2023	17.5%
Spain	Gout	0.757842015781554	2023	75.8%
Spain	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.242157984218446	2023	24.2%
Switzerland	Gout	0.843113101927198	2023	84.3%
Switzerland	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.156886898072802	2023	15.7%
Portugal	Gout	0.738214111490286	2023	73.8%
Portugal	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.261785888509713	2023	26.2%
Sweden	Gout	0.849368901099936	2023	84.9%
Sweden	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.150631098900064	2023	15.1%
United Kingdom	Gout	0.717575734067869	2023	71.8%
United Kingdom	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.282424265932131	2023	28.2%
Argentina	Gout	0.913997503316076	2023	91.4%
Argentina	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.0860024966839242	2023	8.6%
Uruguay	Gout	0.822237303266069	2023	82.2%
Uruguay	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.17776269673393	2023	17.8%
Southern Latin America	Gout	0.877981811791049	2023	87.8%
Southern Latin America	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.122018188208951	2023	12.2%
Chile	Gout	0.820687097961622	2023	82.1%
Chile	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.179312902038378	2023	17.9%
High-income North America	Gout	0.820275132663967	2023	82%
High-income North America	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.179724867336033	2023	18%
Caribbean	Gout	0.680043180342112	2023	68%
Caribbean	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.319956819657888	2023	32%
United States of America	Gout	0.823002213430927	2023	82.3%
United States of America	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.176997786569073	2023	17.7%
Canada	Gout	0.797128421047017	2023	79.7%
Canada	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.202871578952983	2023	20.3%
Antigua and Barbuda	Gout	0.676169396214019	2023	67.6%
Antigua and Barbuda	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.323830603785982	2023	32.4%
Cuba	Gout	0.749131196066238	2023	74.9%
Cuba	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.250868803933762	2023	25.1%
Barbados	Gout	0.589998282773081	2023	59%
Barbados	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.410001717226919	2023	41%
Belize	Gout	0.634282462425524	2023	63.4%
Belize	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.365717537574476	2023	36.6%
Bahamas	Gout	0.566033476890051	2023	56.6%
Bahamas	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.433966523109949	2023	43.4%
Dominica	Gout	0.620156007653539	2023	62%
Dominica	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.379843992346461	2023	38%
Grenada	Gout	0.744289428905807	2023	74.4%
Grenada	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.255710571094193	2023	25.6%
Dominican Republic	Gout	0.700547993966	2023	70.1%
Dominican Republic	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.299452006034	2023	29.9%
Guyana	Gout	0.537964462015481	2023	53.8%
Guyana	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.462035537984519	2023	46.2%
Jamaica	Gout	0.68180566246078	2023	68.2%
Jamaica	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.31819433753922	2023	31.8%
Saint Vincent and the Grenadines	Gout	0.75476952061832	2023	75.5%
Saint Vincent and the Grenadines	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.24523047938168	2023	24.5%
Haiti	Gout	0.75566039306144	2023	75.6%
Haiti	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.24433960693856	2023	24.4%
Saint Lucia	Gout	0.752762975397917	2023	75.3%
Saint Lucia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.247237024602083	2023	24.7%
Suriname	Gout	0.624659371058396	2023	62.5%
Suriname	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.375340628941604	2023	37.5%
Andean Latin America	Gout	0.643621861536031	2023	64.4%
Andean Latin America	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.356378138463969	2023	35.6%
Ecuador	Gout	0.625528862122778	2023	62.6%
Ecuador	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.374471137877222	2023	37.4%
Trinidad and Tobago	Gout	0.615573682964177	2023	61.6%
Trinidad and Tobago	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.384426317035822	2023	38.4%
Bolivia (Plurinational State of)	Gout	0.606537695608298	2023	60.7%
Bolivia (Plurinational State of)	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.393462304391702	2023	39.3%
Peru	Gout	0.665825353078739	2023	66.6%
Peru	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.334174646921261	2023	33.4%
Colombia	Gout	0.632040383871054	2023	63.2%
Colombia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.367959616128946	2023	36.8%
El Salvador	Gout	0.586861378999055	2023	58.7%
El Salvador	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.413138621000945	2023	41.3%
Central Latin America	Gout	0.567918530890047	2023	56.8%
Central Latin America	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.432081469109953	2023	43.2%
Costa Rica	Gout	0.410078566083963	2023	41%
Costa Rica	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.589921433916037	2023	59%
Guatemala	Gout	0.378341442353306	2023	37.8%
Guatemala	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.621658557646694	2023	62.2%
Mexico	Gout	0.57504057006708	2023	57.5%
Mexico	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.42495942993292	2023	42.5%
Honduras	Gout	0.640373644547604	2023	64%
Honduras	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.359626355452396	2023	36%
Nicaragua	Gout	0.507044057085409	2023	50.7%
Nicaragua	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.492955942914591	2023	49.3%
Venezuela (Bolivarian Republic of)	Gout	0.570671654283979	2023	57.1%
Venezuela (Bolivarian Republic of)	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.429328345716021	2023	42.9%
Brazil	Gout	0.750315947487787	2023	75%
Brazil	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.249684052512213	2023	25%
Panama	Gout	0.564622428563288	2023	56.5%
Panama	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.435377571436712	2023	43.5%
Tropical Latin America	Gout	0.749344633151457	2023	74.9%
Tropical Latin America	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.250655366848543	2023	25.1%
Paraguay	Gout	0.707469866264423	2023	70.7%
Paraguay	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.292530133735577	2023	29.3%
North Africa and Middle East	Gout	0.444988442651286	2023	44.5%
North Africa and Middle East	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.555011557348714	2023	55.5%
Bahrain	Gout	0.682835688762802	2023	68.3%
Bahrain	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.317164311237198	2023	31.7%
Algeria	Gout	0.776971718004338	2023	77.7%
Algeria	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.223028281995662	2023	22.3%
Egypt	Gout	0.18819118544119	2023	18.8%
Egypt	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.81180881455881	2023	81.2%
Iraq	Gout	0.364117299755387	2023	36.4%
Iraq	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.635882700244613	2023	63.6%
Iran (Islamic Republic of)	Gout	0.654273862138607	2023	65.4%
Iran (Islamic Republic of)	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.345726137861393	2023	34.6%
Kuwait	Gout	0.882354967175679	2023	88.2%
Kuwait	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.117645032824321	2023	11.8%
Jordan	Gout	0.782772466815676	2023	78.3%
Jordan	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.217227533184324	2023	21.7%
Lebanon	Gout	0.638117166301475	2023	63.8%
Lebanon	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.361882833698525	2023	36.2%
Libya	Gout	0.469785814729394	2023	47%
Libya	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.530214185270606	2023	53%
Morocco	Gout	0.442017283023059	2023	44.2%
Morocco	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.557982716976941	2023	55.8%
Palestine	Gout	0.523756027172815	2023	52.4%
Palestine	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.476243972827185	2023	47.6%
Oman	Gout	0.533541140543367	2023	53.4%
Oman	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.466458859456633	2023	46.6%
Qatar	Gout	0.757283839224424	2023	75.7%
Qatar	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.242716160775576	2023	24.3%
Saudi Arabia	Gout	0.573728407892598	2023	57.4%
Saudi Arabia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.426271592107402	2023	42.6%
Syrian Arab Republic	Gout	0.521433419689309	2023	52.1%
Syrian Arab Republic	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.478566580310691	2023	47.9%
Tunisia	Gout	0.766202758449285	2023	76.6%
Tunisia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.233797241550715	2023	23.4%
Turkey	Gout	0.711215806123227	2023	71.1%
Turkey	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.288784193876773	2023	28.9%
United Arab Emirates	Gout	0.807443369013988	2023	80.7%
United Arab Emirates	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.192556630986012	2023	19.3%
Yemen	Gout	0.710931437494294	2023	71.1%
Yemen	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.289068562505706	2023	28.9%
South Asia	Gout	0.682255423710977	2023	68.2%
South Asia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.317744576289023	2023	31.8%
Afghanistan	Gout	0.682854294837209	2023	68.3%
Afghanistan	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.317145705162791	2023	31.7%
Bangladesh	Gout	0.611515915220713	2023	61.2%
Bangladesh	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.388484084779287	2023	38.8%
Bhutan	Gout	0.691299934127201	2023	69.1%
Bhutan	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.308700065872799	2023	30.9%
India	Gout	0.68521608651355	2023	68.5%
India	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.31478391348645	2023	31.5%
Nepal	Gout	0.782053491139841	2023	78.2%
Nepal	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.217946508860159	2023	21.8%
Pakistan	Gout	0.707674106941818	2023	70.8%
Pakistan	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.292325893058182	2023	29.2%
Central Sub-Saharan Africa	Gout	0.293639179145944	2023	29.4%
Central Sub-Saharan Africa	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.706360820854056	2023	70.6%
Angola	Gout	0.363143472857966	2023	36.3%
Angola	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.636856527142034	2023	63.7%
Central African Republic	Gout	0.413001201379206	2023	41.3%
Central African Republic	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.586998798620794	2023	58.7%
Congo	Gout	0.460430685105117	2023	46%
Congo	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.539569314894883	2023	54%
Democratic the Congo	Gout	0.263325278387938	2023	26.3%
Democratic the Congo	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.736674721612062	2023	73.7%
Equatorial Guinea	Gout	0.3523016359904	2023	35.2%
Equatorial Guinea	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.6476983640096	2023	64.8%
Gabon	Gout	0.350888801611241	2023	35.1%
Gabon	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.649111198388759	2023	64.9%
Eastern Sub-Saharan Africa	Gout	0.575458288511904	2023	57.5%
Eastern Sub-Saharan Africa	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.424541711488097	2023	42.5%
Burundi	Gout	0.626013255899222	2023	62.6%
Burundi	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.373986744100778	2023	37.4%
Comoros	Gout	0.759792725047859	2023	76%
Comoros	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.240207274952141	2023	24%
Djibouti	Gout	0.533161228536294	2023	53.3%
Djibouti	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.466838771463706	2023	46.7%
Eritrea	Gout	0.625271733835412	2023	62.5%
Eritrea	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.374728266164588	2023	37.5%
Ethiopia	Gout	0.65085015680921	2023	65.1%
Ethiopia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.34914984319079	2023	34.9%
Kenya	Gout	0.56389473370983	2023	56.4%
Kenya	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.43610526629017	2023	43.6%
Madagascar	Gout	0.514505487421224	2023	51.5%
Madagascar	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.485494512578776	2023	48.5%
Malawi	Gout	0.562475267158602	2023	56.2%
Malawi	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.437524732841397	2023	43.8%
Mozambique	Gout	0.47358648297211	2023	47.4%
Mozambique	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.52641351702789	2023	52.6%
Mauritius	Gout	0.887850796373373	2023	88.8%
Mauritius	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.112149203626627	2023	11.2%
Seychelles	Gout	0.666261063950565	2023	66.6%
Seychelles	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.333738936049435	2023	33.4%
Rwanda	Gout	0.506353458998042	2023	50.6%
Rwanda	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.493646541001958	2023	49.4%
Somalia	Gout	0.576521215463516	2023	57.7%
Somalia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.423478784536484	2023	42.3%
Uganda	Gout	0.46091457486998	2023	46.1%
Uganda	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.53908542513002	2023	53.9%
United Tanzania	Gout	0.686920349526958	2023	68.7%
United Tanzania	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.313079650473042	2023	31.3%
Southern Sub-Saharan Africa	Gout	0.495100075638666	2023	49.5%
Southern Sub-Saharan Africa	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.504899924361334	2023	50.5%
Zambia	Gout	0.545170758218718	2023	54.5%
Zambia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.454829241781282	2023	45.5%
Botswana	Gout	0.602005149248359	2023	60.2%
Botswana	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.397994850751641	2023	39.8%
Lesotho	Gout	0.494518117159309	2023	49.5%
Lesotho	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.50548188284069	2023	50.5%
Namibia	Gout	0.725911350160374	2023	72.6%
Namibia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.274088649839626	2023	27.4%
South Africa	Gout	0.487317752418207	2023	48.7%
South Africa	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.512682247581793	2023	51.3%
Eswatini	Gout	0.538960048014035	2023	53.9%
Eswatini	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.461039951985965	2023	46.1%
Zimbabwe	Gout	0.501999328079138	2023	50.2%
Zimbabwe	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.498000671920862	2023	49.8%
Benin	Gout	0.702772471365406	2023	70.3%
Benin	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.297227528634594	2023	29.7%
Western Sub-Saharan Africa	Gout	0.458560430199237	2023	45.9%
Western Sub-Saharan Africa	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.541439569800763	2023	54.1%
Burkina Faso	Gout	0.682185069604828	2023	68.2%
Burkina Faso	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.317814930395172	2023	31.8%
Cameroon	Gout	0.34439431017079	2023	34.4%
Cameroon	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.65560568982921	2023	65.6%
Cabo Verde	Gout	0.400799681816565	2023	40.1%
Cabo Verde	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.599200318183435	2023	59.9%
Chad	Gout	0.339112318318844	2023	33.9%
Chad	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.660887681681156	2023	66.1%
Cote d'Ivoire	Gout	0.48218227495772	2023	48.2%
Cote d'Ivoire	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.517817725042281	2023	51.8%
Gambia	Gout	0.26563324953161	2023	26.6%
Gambia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.73436675046839	2023	73.4%
Ghana	Gout	0.439835652699424	2023	44%
Ghana	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.560164347300576	2023	56%
Guinea	Gout	0.298536650766787	2023	29.9%
Guinea	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.701463349233213	2023	70.1%
Guinea-Bissau	Gout	0.440141981855553	2023	44%
Guinea-Bissau	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.559858018144447	2023	56%
Liberia	Gout	0.256309349762548	2023	25.6%
Liberia	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.743690650237452	2023	74.4%
Mali	Gout	0.327987574325744	2023	32.8%
Mali	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.672012425674256	2023	67.2%
Mauritania	Gout	0.211537251496945	2023	21.2%
Mauritania	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.788462748503055	2023	78.8%
Niger	Gout	0.616617901953585	2023	61.7%
Niger	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.383382098046415	2023	38.3%
Sao Tome and Principe	Gout	0.429404396183476	2023	42.9%
Sao Tome and Principe	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.570595603816524	2023	57.1%
Nigeria	Gout	0.530749588694058	2023	53.1%
Nigeria	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.469250411305942	2023	46.9%
Senegal	Gout	0.441377937409861	2023	44.1%
Senegal	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.558622062590139	2023	55.9%
Sierra Leone	Gout	0.40586130040958	2023	40.6%
Sierra Leone	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.59413869959042	2023	59.4%
Togo	Gout	0.469766571833892	2023	47%
Togo	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.530233428166108	2023	53%
Bermuda	Gout	0.68166850376914	2023	68.2%
Bermuda	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.31833149623086	2023	31.8%
American Samoa	Gout	0.514253285295314	2023	51.4%
American Samoa	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.485746714704686	2023	48.6%
Cook Islands	Gout	0.342075858972523	2023	34.2%
Cook Islands	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.657924141027478	2023	65.8%
Guam	Gout	0.609080164517968	2023	60.9%
Guam	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.390919835482032	2023	39.1%
Greenland	Gout	0.816831393506967	2023	81.7%
Greenland	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.183168606493033	2023	18.3%
Monaco	Gout	0.628306255319827	2023	62.8%
Monaco	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.371693744680173	2023	37.2%
Niue	Gout	0.553187201895142	2023	55.3%
Niue	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.446812798104858	2023	44.7%
Nauru	Gout	0.291228899638315	2023	29.1%
Nauru	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.708771100361685	2023	70.9%
Northern Mariana Islands	Gout	0.483423026007401	2023	48.3%
Northern Mariana Islands	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.516576973992599	2023	51.7%
Puerto Rico	Gout	0.545857402275299	2023	54.6%
Puerto Rico	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.454142597724701	2023	45.4%
San Marino	Gout	0.909857910704947	2023	91%
San Marino	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.0901420892950531	2023	9%
Saint Kitts and Nevis	Gout	0.578162988634256	2023	57.8%
Saint Kitts and Nevis	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.421837011365744	2023	42.2%
Palau	Gout	0.564201791933814	2023	56.4%
Palau	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.435798208066186	2023	43.6%
Tokelau	Gout	0.576451375991352	2023	57.6%
Tokelau	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.423548624008648	2023	42.4%
United States Virgin Islands	Gout	0.692354029503107	2023	69.2%
United States Virgin Islands	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.307645970496893	2023	30.8%
South Sudan	Gout	0.517233514098093	2023	51.7%
South Sudan	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.482766485901906	2023	48.3%
Sudan	Gout	0.450008445081327	2023	45%
Sudan	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.549991554918673	2023	55%
Tuvalu	Gout	0.438526002285124	2023	43.9%
Tuvalu	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.561473997714876	2023	56.1%
Low-middle SDI	Gout	0.632975173490452	2023	63.3%
Low-middle SDI	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.367024826509548	2023	36.7%
High-middle SDI	Gout	0.661359407218412	2023	66.1%
High-middle SDI	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.338640592781588	2023	33.9%
Low SDI	Gout	0.535167751980569	2023	53.5%
Low SDI	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.464832248019431	2023	46.5%
Middle SDI	Gout	0.499035265708983	2023	49.9%
Middle SDI	Total burden related to Non-alcoholic fatty liver disease (NAFLD)	0.500964734291017	2023	50.1%
